E815
TEAS SECTION 8 & 15 RECEIVED
06/02/2026
Back to search
Official data from USPTO
REVANESSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
06/03/2026
Trademark type
Combined
Nice classes
5
Filing date
02/07/2019
Registration date
06/02/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2020
Last transaction
06/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Aurora, Ontario, CA
Examiner
GIPSOV, MARYNA K
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "REVANESSE" in stylized font.
Holders and representatives
Holders
Prollenium Medical Technologies, Inc.
Representatives
Cassandra L. Wilkinson HEAD, JOHNSON, KACHIGIAN & WILKINSON, PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Syringes containing hyaluronic acid gel for use in cosmetic treatment procedures and wound healing
Publications
History of USPTO decisions and trademark events.
32 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/02/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/17/2020
PUBO
PUBLISHED FOR OPPOSITION
03/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/21/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/17/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/13/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/13/2020
CNSI
SUSPENSION INQUIRY WRITTEN
01/13/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/18/2019
ALIE
ASSIGNED TO LIE
12/13/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/13/2019
GNSL
LETTER OF SUSPENSION E-MAILED
05/13/2019
CNSL
SUSPENSION LETTER WRITTEN
05/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
05/02/2019
GPRA
PRIORITY ACTION E-MAILED
05/02/2019
CPRA
PRIORITY ACTION WRITTEN
05/02/2019
DOCK
ASSIGNED TO EXAMINER
04/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2019
NWAP
NEW APPLICATION ENTERED
02/11/2019
Continuous trademark protection
Get notified about every new filing that threatens REVANESSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.